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This standard is based on NG64 and PH28. 
This standard should be read in conjunction with QS59, QS31, QS23 and QS116. 
Quality statements 
Statement 1 Looked-after children and young people having their annual health plan review are 
assessed for vulnerability to drug misuse. 
Statement 2 Care leavers having a health assessment as part of planning to leave care are assessed 
for vulnerability to drug misuse. 
Statement 3 Children and young people having a young offender assessment are assessed for 
vulnerability to drug misuse. 
Statement 4 Adults assessed as vulnerable to drug misuse are given information about local 
services and where to find further advice and support. 
NICE has developed guidance and a quality standard on patient experience in adult NHS 
services (see the NICE Pathway on patient experience in adult NHS services), which should be 
considered alongside these quality statements. 
Other quality standards that should be considered when commissioning or providing drug 
misuse prevention services include: 
• Antisocial behaviour and conduct disorders in children and young people (2014) NICE 
quality standard 59 
• Looked-after children and young people (2013) NICE quality standard 31 
• Drug use disorders in adults (2012) NICE quality standard 23. 
A full list of NICE quality standards is available from the quality standards topic library. 
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Quality statement 1: Assessment of looked-after 
children and young people 
Quality statement 
Looked-after children and young people having their annual health plan review are assessed for 
vulnerability to drug misuse. 
Rationale 
Looked-after children and young people are at increased risk of drug misuse. Assessing 
vulnerability as part of their annual health plan review provides an opportunity to give early 
targeted support, which can reduce the likelihood of drug misuse. 
Quality measures 
Structure 
a) Evidence of local arrangements for the use of an agreed brief and valid questionnaire to assess 
looked-after children and young people's vulnerability to drug misuse at their annual health plan 
review. 
Data source: Local data collection, for example, from service specifications. 
b) Evidence of local arrangements for staff to be trained by specialist services in how to assess 
looked-after children and young people's vulnerability to drug misuse. 
Data source: Local data collection, for example, from service specifications. 
Process 
Proportion of looked-after children and young people having their annual health plan review who 
have an assessment of vulnerability to drug misuse. 
Numerator – the number in the denominator who have an assessment of vulnerability to drug 
misuse. 
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Denominator – the number of looked-after children and young people who have had a health plan 
review in the previous 12 months. 
Data source: Local data collection, for example, local audit of local authority records. 
Outcome 
a) Number of looked-after children and young people who misuse drugs. 
Data source:Local data collection. 
b) Proportion of looked-after children and young people misusing drugs, who access support for 
drug misuse. 
Data source:Local data collection. Data collection is required for the children looked after data 
return (SSDA903) on whether children looked after by local authorities in England are identified as 
having a substance misuse problem for each year up to 31 March. 
What the quality statement means for different 
audiences 
Service providers (such as primary care services and looked-after children health teams) ensure 
that staff who assess the health of looked-after children are provided with guidance and training 
from specialist services so that they know the indicators of drug misuse, how to approach the 
assessment with sensitivity, how to use brief questionnaires (such as CRAFFT) accurately and how 
to respond to identified needs. They ensure that arrangements are in place for assessments to be 
included in the annual health plan review. 
Healthcare professionals (such as GPs and school nurses) use a consistent, locally agreed brief and 
valid questionnaire, such as CRAFFT, to assess looked-after children and young people for 
vulnerability to drug misuse at their annual health plan review. They use an approach that is 
respectful, non-judgemental and proportionate to the young person's presenting vulnerabilities, 
and consider whether any further action is needed. 
Commissioners (NHS England and local authorities) work with providers to produce a strategy to 
identify looked-after children and young people who are at risk of drug misuse. They ensure that 
they commission services in which looked-after children and young people have an assessment of 
vulnerability to drug misuse at their annual health plan review. 
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Children and young people who are looked after are asked brief questions at their annual health 
plan review to assess whether they are at risk of drug misuse. This is so that their needs can be 
identified and responded to. 
Source guidance 
• Drug misuse prevention: targeted interventions (2017) NICE guideline NG64, 
recommendation 1.2.1 
• Looked-after children and young people (2010, updated 2015) NICE guideline PH28, 
recommendation 20 
Definitions of terms used in this quality statement 
Assessment of vulnerability to drug misuse 
An assessment that is respectful, non-judgemental and proportionate to the child or young person's 
presenting vulnerabilities that uses a consistent, locally agreed, brief and valid questionnaire, such 
as CRAFFT. The child or young person's circumstances should be discussed, taking account of their 
age and developmental stage. The initial discussion could include: 
• their physical and mental health and their personal, social, educational or employment 
circumstances (which may trigger a more in-depth assessment) 
• any drug use (including the type used and how often). 
[Adapted from NICE's guideline on drug misuse prevention, recommendations 1.2.2 and 1.2.3, and 
College Centre for Quality Improvement's Practice standards for young people with substance 
misuse problems] 
Health plan review 
A looked-after child has a health plan review at least once every 12 months from the age of 5. 
A looked-after child or young person's health plan forms part of their wider care plan. It is based on 
the written report of the health assessment, which takes place before the child or young person is 
placed with the local authority, or if that is not reasonably practicable, before their first case review. 
[Adapted from the Care Planning, Placement and Case Review (England) Regulations 2010] 
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Quality statement 2: Assessment of care leavers 
Quality statement 
Care leavers having a health assessment as part of planning to leave care are assessed for 
vulnerability to drug misuse. 
Rationale 
The transition from care is an important time for young people to receive a comprehensive 
assessment of their physical, emotional and mental health needs, as part of planning to leave care. 
Assessing a care leaver's vulnerability to drug misuse provides an opportunity to identify risks and 
give them targeted support. 
Quality measures 
Structure 
a) Evidence of local arrangements for the use of an agreed brief and valid questionnaire to assess 
care leavers' vulnerability to drug misuse at their health assessment. 
Data source: Local data collection, for example, from service specifications. 
b) Evidence of local arrangements for staff to be trained by specialist services in how to assess care 
leavers' vulnerability to drug misuse. 
Data source: Local data collection, for example, from service specifications. 
Process 
Proportion of care leavers having a health assessment as part of planning to leave care who have an 
assessment of vulnerability to drug misuse. 
Numerator – the number in the denominator where there is an assessment of vulnerability to drug 
misuse. 
Denominator – the number of care leavers having a health assessment as part of planning to leave 
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Data source: Local data collection, for example, audit of local authority records. 
Outcome 
a) Number of care leavers who misuse drugs. 
Data source:Local data collection. 
b) Proportion of care leavers misusing drugs who access support for drug misuse. 
Data source:Local data collection. Data collection is required for the children looked after data 
return (SSDA903) on whether children looked after by local authorities in England are identified as 
having a substance misuse problem for each year up to 31 March. 
What the quality statement means for different 
audiences 
Service providers (such as primary care services and social care services) ensure that assessments 
of care leavers' vulnerability to drug misuse are carried out as part of their health assessments. 
They also ensure that staff are provided with guidance and training from specialist services so that 
they know the indicators of drug use, how to approach the assessment with sensitivity, how to use 
brief questionnaires such as CRAFFT accurately, and how to respond to identified needs. 
Health and social care practitioners (such as GPs and social workers) use a consistent, locally 
agreed brief and valid questionnaire, such as CRAFFT, to assess care leavers for vulnerability to 
drug misuse at their health assessment. They use an approach that is respectful, non-judgemental 
and proportionate to the young person's presenting vulnerabilities, and consider whether any 
further action is needed. 
Commissioners (NHS England and local authorities) work with providers to produce a strategy to 
identify young people who are at risk of drug misuse. They ensure that they commission services in 
which care leavers have an assessment of vulnerability to drug misuse at their health assessment. 
Care leavers are asked brief questions at their health assessment to assess whether they are at risk 
of drug misuse. This is so that their needs can be identified and responded to. 
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• Drug misuse prevention: targeted interventions (2017) NICE guideline NG64, 
recommendation 1.2.1 
• Looked-after children and young people (2010, updated 2015) NICE guideline PH28, 
recommendation 46 
Definitions of terms used in this quality statement 
Assessment of vulnerability to drug misuse 
An assessment that is respectful, non-judgemental and proportionate to the young person's 
presenting vulnerabilities that uses a consistent, locally agreed, brief and valid questionnaire, such 
as CRAFFT. The young person's circumstances should be discussed, taking account of their age and 
developmental stage. The initial discussion could include: 
• their physical and mental health and their personal, social, educational or employment 
circumstances (which may trigger a more in-depth assessment) 
• any drug use (including the type used and how often). 
[Adapted from NICE's guideline on drug misuse prevention, recommendations 1.2.2 and 1.2.3, and 
College Centre for Quality Improvement's Practice standards for young people with substance 
misuse problems] 
Health assessment 
When developing a pathway plan for young people preparing to leave care, an assessment of the 
needs of the young person should be carried out that includes their health and development. 
[Adapted from The Care Leavers (England) Regulations 2010] 
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Quality statement 3: Assessment of children and 
young people in contact with youth offending 
services 
Quality statement 
Children and young people having a young offender assessment are assessed for vulnerability to 
drug misuse. 
Rationale 
Children and young people who are in contact with youth offending services are at increased risk of 
drug misuse. Youth offending teams can use young offender assessments to assess vulnerability. 




a) Evidence of local arrangements for the use of an agreed brief and valid questionnaire to assess 
children and young people's vulnerability to drug misuse at young offender assessments. 
Data source: Local data collection, for example, from service specifications. 
b) Evidence of local arrangements for staff to be trained in how to assess children and young 
people's vulnerability to drug misuse. 
Data source: Local data collection, for example, from service specifications. 
Process 
Proportion of young offender assessments which include an assessment of vulnerability to drug 
misuse. 
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Numerator – the number in the denominator which include an assessment of vulnerability to drug 
misuse. 
Denominator – the number of young offender assessments. 
Data source: Local data collection, for example, audit of records. 
Outcome 
a) Number of children and young people in contact with youth offending services who misuse 
drugs. 
Data source:Local data collection. 
b) Proportion of children and young people who are in contact with youth offending services, 
misusing drugs, who access support for drug misuse. 
Data source:Local data collection. 
What the quality statement means for different 
audiences 
Service providers (youth offending teams) ensure that staff use a consistent, locally agreed brief 
and valid questionnaire, such as CRAFFT, to assess children and young people for vulnerability to 
drug misuse at young offender assessments. Staff are also provided with guidance and training 
from specialist services so that they know the indicators of drug use, how to approach the 
assessment with sensitivity, how to use brief questionnaires accurately and how to respond to 
identified needs. 
Youth offending team workers and managers use a consistent, locally agreed brief and valid 
questionnaire, such as CRAFFT, to assess children and young people who are having a young 
offender assessment for vulnerability to drug misuse. They use an approach that is respectful, non-
judgemental and proportionate to the young person's presenting vulnerabilities, and consider 
whether any further action is needed. 
Commissioners (local authorities, Youth Justice Board) ensure that they commission services in 
which children and young people who are having a young offender assessment or review have an 
assessment of vulnerability to drug misuse. 
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Children and young people children who are having a young offender assessment with a youth 
offending team are asked brief questions to assess whether they are vulnerable to drug misuse. 
This is so that their needs can identified and responded to. 
Source guidance 
Drug misuse prevention: targeted interventions (2017) NICE guideline NG64, recommendation 
1.2.1 
Definitions of terms used in this quality statement 
Assessment of vulnerability to drug misuse 
An assessment that is respectful, non-judgemental and proportionate to the young person's 
presenting vulnerabilities that uses a consistent, locally agreed, brief and valid questionnaire, such 
as CRAFFT. The child or young person's circumstances should be discussed, taking account of their 
age and developmental stage. The initial discussion could include: 
• their physical and mental health and their personal, social, educational or employment 
circumstances (which may trigger a more in-depth assessment) 
• any drug use (including the type used and how often and relationship between their offending 
and drug use). 
[Adapted from NICE's guideline on drug misuse prevention, recommendations 1.2.2 and 1.2.3, and 
College Centre for Quality Improvement's Practice standards for young people with substance 
misuse problems] 
Young offender assessment 
The young offender assessment process is designed to find out the risk and protective factors 
playing a part in a young person's offending. 'AssetPlus' is the Youth Justice Board for England and 
Wales's comprehensive end-to-end assessment and planning framework approved by the Youth 
Justice Board for England and Wales. 
[How to assess children in the youth justice system: section 4 case management guidance, Youth 
Justice Board] 
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Quality statement 4: Information and advice for 
adults 
Quality statement 
Adults assessed as vulnerable to drug misuse are given information about local services and where 
to find further advice and support. 
Rationale 
It is important that adults who have been assessed as vulnerable to drug misuse are provided with 
clear information and advice on the harms of drugs use and where to get help. This can help to 
reduce the likelihood of the misuse of drugs, such as preventing drug dependency. 
Quality measures 
Structure 
Evidence of local arrangements to provide written information about local services and where to 
find further advice and support. 
Data source: Local data collection, for example, list of local services. 
Process 
Proportion of adults assessed as vulnerable to drug misuse who are given information about local 
services and where to find further advice and support. 
Numerator – the number in the denominator who are given information about local services and 
where to find further advice and support. 
Denominator – the number of adults assessed as vulnerable to drug misuse. 
Data source: Local data collection, for example, audit of patient, specialist services monitoring 
reports and service user records. 
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a) Proportion of people aged 16 to 59 years who use drugs frequently. 
Data source:Local data collection. The Home Office produces annual Drug misuse statistics which 
examines the extent and trends in illicit drug use among a sample of residents in households in 
England and Wales. 
b) Proportion of people aged 16 to 24 years who use drugs frequently. 
Data source:Local data collection. The Home Office produces annual Drug misuse statistics which 
examines the extent and trends in illicit drug use among a sample of residents in households in 
England and Wales. 
What the quality statement means for different 
audiences 
Service providers (such as primary and secondary care services, social services, sexual and 
reproductive health services, specialist drug and alcohol services, mental health services, housing 
and benefits, and criminal justice services) have systems in place for adults assessed as vulnerable 
to drug misuse to be given information about local services and where to find further advice and 
support. 
Health and social care practitioners, and criminal justice system professionals (such as GPs, 
community nurses, health visitors, hospital workers, social workers, mental health professionals, 
specialist drug services professionals, police and probation officers) give information about local 
services and where to find further advice and support to adults who are assessed as vulnerable to 
drug misuse. 
Commissioners (NHS England, local authorities, clinical commissioning groups) ensure that they 
commission services where adults assessed as vulnerable to drug misuse are given information 
about local services and where to find further advice and support. 
Adults who are assessed as vulnerable to drug misuse are given information about local services 
and where to find further advice and support. This should be both verbal and written. It should be 
provided in a non-judgemental way and tailored to the person's preferences, needs and level of 
understanding about their health. 
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Drug misuse prevention: targeted interventions (2017) NICE guideline NG64, recommendation 
1.4.1 
Definitions of terms used in this quality statement 
Information on local services and where to find further advice and 
support 
Information and advice given should be both verbal and in writing. 
For general information about drugs, a reputable source should be given for where people can 
access further information, such as the NHS website. Information about local services should also 
be provided so that support can be accessed as needed. 
[Adapted from NICE's guideline on drug misuse prevention, recommendations 1.4.1 and 1.4.2 and 
expert opinion] 
Equality and diversity considerations 
Information about drug misuse should be accessible to people with additional needs such as 
physical, sensory or learning disabilities, and to people (including families and carers) who do not 
speak or read English or who have reduced literacy skills. People should have access to an 
interpreter or advocate if needed. 
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About this quality standard 
NICE quality standards describe high-priority areas for quality improvement in a defined care or 
service area. Each standard consists of a prioritised set of specific, concise and measurable 
statements. NICE quality standards draw on existing NICE or NICE-accredited guidance that 
provides an underpinning, comprehensive set of recommendations, and are designed to support 
the measurement of improvement. 
Expected levels of achievement for quality measures are not specified. Quality standards are 
intended to drive up the quality of care, and so achievement levels of 100% should be aspired to (or 
0% if the quality statement states that something should not be done). However, this may not 
always be appropriate in practice. Taking account of safety, shared decision-making, choice and 
professional judgement, desired levels of achievement should be defined locally. 
Information about how NICE quality standards are developed is available from the NICE website. 
See quality standard advisory committees on the website for details of standing committee 2 
members who advised on this quality standard. Information about the topic experts invited to join 
the standing members is available on the quality standard's webpage. 
This quality standard has been incorporated into the NICE Pathways on drug misuse prevention 
and looked-after babies, children and young people. 
NICE has produced a quality standard service improvement template to help providers make an 
initial assessment of their service compared with a selection of quality statements. This tool is 
updated monthly to include new quality standards. 
NICE produces guidance, standards and information on commissioning and providing high-quality 
healthcare, social care, and public health services. We have agreements to provide certain NICE 
services to Wales, Scotland and Northern Ireland. Decisions on how NICE guidance and other 
products apply in those countries are made by ministers in the Welsh government, Scottish 
government, and Northern Ireland Executive. NICE guidance or other products may include 
references to organisations or people responsible for commissioning or providing care that may be 
relevant only to England. 
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This quality standard is expected to contribute to improvements in the following outcomes: 
• Mortality from drug misuse 
• Emotional wellbeing of people at risk of drug misuse 
• Hospital admissions from drug misuse 
• Entrants and re-entrants to the criminal justice system who are misusing drugs 
• Educational attainment of children and young people at risk of misusing drugs 
• Unemployment of people who are misusing drugs 
• Accident and emergency attendances from drug misuse 
It is also expected to support delivery of the Department of Health and Social Care outcome 
frameworks: 
• Adult social care outcomes framework 2015–16 
• NHS outcomes framework 2016–17 
• Public health outcomes framework for England, 2016–19. 
Resource impact 
NICE quality standards should be achievable by local services. The potential resource impact is 
considered by the quality standards advisory committee, drawing on resource impact work for the 
source guidance. Organisations are encouraged to use the resource impact statement for the 
source guidance to help estimate local costs. 
Diversity, equality and language 
During the development of this quality standard, equality issues were considered and equality 
assessments are available. Any specific issues identified during development of the quality 
statements are highlighted in each statement. 
Commissioners and providers should aim to achieve the quality standard in their local context, in 
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light of their duties to have due regard to the need to eliminate unlawful discrimination, advance 
equality of opportunity and foster good relations. Nothing in this quality standard should be 
interpreted in a way that would be inconsistent with compliance with those duties. 
ISBN: 978-1-4731-2903-0 
Endorsing organisation 
This quality standard has been endorsed by Department of Health and Social Care, as required by 
the Health and Social Care Act (2012) 
Supporting organisations 
Many organisations share NICE's commitment to quality improvement using evidence-based 
guidance. The following supporting organisations have recognised the benefit of the quality 
standard in improving care for patients, carers, service users and members of the public. They have 
agreed to work with NICE to ensure that those commissioning or providing services are made 
aware of and encouraged to use the quality standard. 
• Public Health England 
• Royal College of Physicians (RCP) 
• Addaction 
• Royal College of General Practitioners (RCGP) 
• Royal College of Nursing (RCN) 
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